key: cord-1019541-xopllvk5
authors: Salcedo-Varea, G. A.; Penunuri, F.; Gonzalez-Sanchez, D.; Diaz-Infante, S.
title: Optimal piecewise constant vaccination and lockdown policies for COVID-19
date: 2021-01-15
journal: nan
DOI: 10.1101/2021.01.13.21249773
sha: 212c2508b83711caba89e53f0095162d31cd490a
doc_id: 1019541
cord_uid: xopllvk5

We formulate a controlled system of ordinary differential equations, with vaccination and lockdown interventions as controls, to simulate the mitigation of COVID-19. The performance of the controls is measured through a cost functional involving vaccination and lockdown costs as well as the burden of COVID19 quantified in DALYs. We calibrate parameters with data from Mexico City and Valle de Mexico. By using differential evolution, we minimize the cost functional subject to the controlled system and find optimal policies that are constant in time intervals of a given size. The main advantage of these policies relies on its practical implementation since the health authority has to make only a finite number of different decisions. Our methodology to find optimal policies is relatively general, allowing changes in the dynamics, the cost functional, or the frequency the policymaker changes actions.

(A-3) Susceptible individuals become exposed-but not infectious-when they are in contact with asymp-71 tomatic or symptomatic individuals. Thus β S and β A denote the probabilities of being infectious 72 given the contact with a symptomatic or asymptomatic infectious individuals, respectively.

(A-4) After a period of latency 1/κ = 5.1 days, an exposed individual becomes infected. Being p the proba-74 bility of developing symptoms and (1 − p) the probability of becoming infectious but asymptomatic. 75 Thus pκE denotes the exposed individuals that become infectious and develop symptoms. Figure 1 : Compartmental diagram of COVID-19 transmission dynamics. Consider the class: Susceptible (S), exposed (E), symptomatic infected (I S ), asymptomatic infected (I A ), recovered (R), death (D) and vaccinated (V ) individuals. It is important to mention that I S represents the proportion of symptomatic individuals who will later report to some health medical center.

Thus we formulate the following Ordinary Differential Equation (ODE), see Figure 1 , to complete the is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 15, 2021. (1) 81 We display in Figure 2 a typical evolution of this COVID-19 spreed dynamics. with mean λ t = IC s (t). Further, following ideas from [11] we postulate priors for p and κ and count the is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint cumulative reported-confirmed cases in the CDMX-Valle de Mexico database [10] 88 Y t ∼ P oisson(λ t ),

κ ∼ Gamma(10, 50).

(2)

Using Van den Driessche's [12] definition of reproductive number we obtain (1) and (2). Table 2 encloses estimated parameters to this setting. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 6 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 15, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 15, 2021. ;

(VH-1) Vaccine is preventive and only reduce susceptibility.

(VH-2) The vaccination camping omits testing to detect seroprevalence. Thus Exposed, Infected Asymp- is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.13.21249773 doi: medRxiv preprint

(3)

The basic reproductive number, which is generally denoted by R 0 , is a threshold quantity we can control with particular strategies. The epidemiological interpretation of R 0 is the average number of secondary cases produced by an infected individual introduced into a population of susceptible individuals. Using van den Driessche's [20] definition of reproductive number we obtain

The factor pβ S R2 measures the proportion of new infections generated by a symptomatic infectious individual in the time that it lasts infected. In a similar way, the factor (1−p)β A γ A +µ measures the new infections generated by an asymptomatic infectious individual in the time that it lasts infected. The factor µR1+δ L δ L +µ measures the number of individuals in lockdown that leave the lockdown, which can be infected. And finally, the factor κ κ+µ measures the time of the disease's incubation. If we consider that there is no lockdown, then R 0 is reduced toR

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

The threshold quantity R V 0 is the reproductive number of infection which can be interpreted as the number is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.13.21249773 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.13.21249773 doi: medRxiv preprint

Now we model vaccination, treatment, and lockdown as an optimal control problem. According to 121 dynamics in Equation (1), we modulate the vaccination rate with a time-dependent control signal u V (t). We 122 add compartment X vac to count all the vaccine applications of lockdown susceptible, exposed, asymptomatic, 123 and recovered individuals. This process is modeled by

and describes the number of applied vaccines at time t. Consider and control signal u v (·). We quantify the cost and reward of a vaccine strategy policy via the penalization

In other words, we assume in functional J that pandemic cost is proportional to the symptomatic hospitalized 

where Ω is the positive invariant set Thus, given the time horizon T , we impose that the last fraction of vaccinated populations corresponds to 132 20%, 50% or 80%, and the rest of final states as free. We also impose the path constraint

to ensure that healthcare services will not be overloaded. Here κ denotes hospitalization rate, and B is the 134 load capacity of a health system.

Given a fixed time horizon and vaccine efficiency, we estimate the constant vaccination rate as the solution

That is, λ V denotes the constant rate to cover a fraction x coverage in time horizon T . Thus, according to this 138 vaccination rate, we postulate a policy u v that modulates vaccination rate according to λ V as a baseline.

That is, optimal vaccination amplifies or attenuates the estimated baseline λ V in a interval [λ min V , λ max V ] to 140 optimize functional J(·)-minimizing symptomatic, death reported cases and optimizing resources. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.13.21249773 doi: medRxiv preprint Figure 9 : Compartmental diagram of COVID-19 transmission dynamics that includes optimal vaccination dynamics, penalization and a path constraint for vaccination policies u V (·), which solve the following optimal control problem (OCP) is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 15, 2021. ;

We simulate a scenario corresponding to a hypothetical but plausible initial conditions and parameters. 147 We integrate model in Equation (9) In the optimization of this study, the mutation scale factor F and the crossover probability C r were taken 157 as 1 and 0.3 respectively, additional N p has been taken as 4 times the number of parameters (the dimension 158 of the vector used to describe the two controls-see [24] ), which in our case was of 180. As stopping criteria 159 we have used a maximum number of generations which is taken as 5000. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 15, 2021. ; Figure 10 : Initial condition scheme. We assume a positive prevalence. For reference, at the date of write this manuscript, prevalence in CDMX is around 16 000 cases, see https://plotly.com/ sauld/36/ to display an electronic viewer. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 15, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 15, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 15, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 15, 2021. ;

Despite that NPIs have been implemented in most countries to mitigate COVID-19, these strategies In this appendix, we show the existence of optimal policies in the class of piecewise constant policies.

Consider the following cost functional that we want to minimize 

for j = 0, . . . , n − 1.

Assumptions 3. We made the following assumptions. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.13.21249773 doi: medRxiv preprint (A-1) The function f in the dynamics (A.2) is of class C 1 .

(A-2) The cost function C in (A.1) is continuous and the set U is compact.

By Assumption (A-1), the system

has a unique solutionX 0 (t; x 0 , a 0 ) which is continuous in (x 0 , a 0 ); see, for instance [27] . Next, put x 1 := 221X 0 (t 1 ; x 0 , a 0 ) and consider the system

Again, by Assumption (A-1), the latter system has a unique solutionX 1 (t; x 1 , a 1 ) which is continuous in (x 1 , a 1 ). By following this procedure, we end up having a recursive solutioñ X n−1 (t; x n−1 , a n−1 ), t n−1 ≤ t ≤ T,

x n−1 :=X n−2 (t n−1 ; x n−2 , a n−1 ), whereX n−1 is continuous in (x n−1 , a n−1 ).

For a controlũ of the form (A.3) and the corresponding solution pathX, we have

Notice that eachX j is a continuous function of (a 0 , . . . , a j ) and x 0 . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 15, 2021. ; https://doi.org/10.1101/2021.01.13.21249773 doi: medRxiv preprint

Model-informed COVID-19 vaccine 233 prioritization strategies by age and serostatus

Vaccine optimization for COVID-19, who to vaccinate first?, medRxiv : the 236 preprint server for health sciences

Modeling shield immunity to reduce COVID-19 epidemic 254 spread

Determination of an Optimal Control Strategy for Vaccine 257

Administration in COVID-19 Pandemic Treatment

World of Health Organization, WHO methods and data sources for global burden of disease estimates

World Health Organization, Datos abiertos sobre salud pública, acciones sociales y gasto público en la Ciudad de México

Modeling behavioral change and COVID-19 con-266 tainment in Mexico: A trade-off between lockdown and compliance

Reproduction numbers and sub-threshold endemic equilibria for compartmental 269 models of disease transmission

Staggered release policies for COVID-19 control: Costs and benefits of relaxing restrictions by age and 271 risk

Pfizer says early analysis shows its Covid-19 vaccine is more than 90% effective, prees release

Russia says its sputnik v covid-19 vaccine is 92% effective, prees release

Moderna's coronavirus vaccine is 94.5% effective, according to company data, prees release updated

Proyecciones de población

Thomp-283 son

Impact of non-pharmaceutical interventions ( NPIs ) to reduce COVID-19 mortality and healthcare de-285 mand

COVID-19 in Korea Using Disability-Adjusted Life Years